Researchers have reported the potency of IGF-1 LR3 peptide to be as much as 3x more than that of IGF-1 (1) , holding a potentially much greater half-life: roughly 20 to 30 hours, compared to the original IGF-1, which has a reported approximate 12 to 15 hours of half-life
While traditional methods like creams, facials, and serums can help, many people now seek faster, medically advanced solutions to achieve visible transformation
Side effects include nausea, particularly during dose escalation, constipation, and potential muscle loss if protein intake is not maintained
Such dynamic adjustments, driven by real-time microbiome data, offer the potential to optimize therapeutic outcomes and minimize the adverse effects of treatment